Modeling Pkd1 gene-targeted strategies for correction of polycystic kidney disease

Almira Kurbegovic1, Rey Christian Pacis1, Marie Trudel1

  • 1Institut de Recherches Cliniques de Montréal, Faculté de, Médecine, Montreal, QC, Canada.

Insights

Gene therapy using Pkd1 gene constructs effectively treated polycystic kidney disease (PKD) in mice. This approach corrected kidney cysts and significantly extended lifespan, offering a promising therapeutic strategy for PKD.

Area of Science:

  • Genetics
  • Molecular Biology
  • Nephrology

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by renal cysts, often leading to end-stage renal disease.
  • Mutations in the PKD1 gene are the primary cause of ADPKD.
  • Effective long-term gene therapeutic strategies for PKD remain largely unexplored.

Purpose of the Study:

  • To investigate the potential of gene therapy for treating polycystic kidney disease (PKD).
  • To evaluate the efficacy of different Pkd1 gene constructs in a mouse model of severe PKD.
  • To determine the impact of Pkd1 re-expression on cyst formation and lifespan.

Main Methods:

  • Utilized a severely cystic Pkd1-null mouse model for gene therapeutic interventions.
  • Administered transgene transfers of genomic Pkd1 (Pkd1^G), kidney-targeted Pkd1 (TnPkd1), and Pkd1^G.
  • Analyzed Pkd1 expression levels, cellular profiles, cyst correction, and lifespan.

Main Results:

  • Pkd1^G constructs with high overexpression (approx. 8-fold) fully complemented the Pkd1-/- phenotype.
  • TnPkd1 transgene transfer (0.6- or 7-fold endogenous levels) corrected glomerular and proximal tubular cysts and delayed other tubular cysts.
  • Renal-targeted Pkd1^G partially rescued all cystic tubular segments, indicating regulation by intragenic sequences.

Conclusions:

  • Re-expression of the Pkd1 gene using therapeutic constructs can ameliorate PKD.
  • Gene therapy significantly extended the lifespan of treated mice.
  • Pkd1 intragenic sequences play a crucial role in regulating gene expression levels and spatiotemporal patterns, essential for therapeutic development.